Chaewon Hwang, M.D.

chaewonhwangmd.bsky.social

17 October 2026 17:30

💡Our real-world analysis showed median time to consolidative #immunotherapy of 84 days from CRT start in Stage III #NSCLC (2018-2021). Uninsured, Medicaid, and tx at non-academic center associated w/ longer time to intiation #ASCOQLTY26 @bidmc-cancercenter.bsky.social @ascocancer.bsky.social

Fumiko Ladd Chino, MD FASCO

fumikochino.bsky.social

17 October 2026 11:40

✈️ En route to Boston (again!) for #ASCOQLTY26. Excited for my favorite meeting of the year! This @ascocancer.bsky.social 2 day conference has the latest science on cancer care delivery, symptom management, survivorship & the patient experience. View full abstracts here: www.asco.org/quality/sear...

Ryan Nipp, MD, MPH, MBA, FASCO

ryannipp.bsky.social

17 October 2026 11:40

So excited to kick off our @ascocancer.bsky.social Quality Care Symposium in Boston tomorrow morning! www.asco.org/quality/prog... #ASCOQLTY #CancerResearch #CancerCare @fumikochino.bsky.social

Hannah R. Abrams

hannahrabrams.bsky.social

17 October 2026 11:40

Starting off strong #ASCOQLTY26! Scott Ramsey @fredhutch.org: Before the Affordable Care Act, 22% of people's credit scores dropped after a cancer diagnosis, and for 10% dropped 50+ points. Since the ACA, that number is down to 15%, and 6% 50+ points. @ascocancer.bsky.social

Chaewon Hwang, M.D.

chaewonhwangmd.bsky.social

17 October 2026 11:40

💡Compelling study on feasibility of consolidative #durvalumab ≤14days after completion of definitive CRT for #NSCLC without added immune-related toxicity. Interesting contrast to TORG1937 (DATE Study) from Japan. Further food for thought for time to tx intiation #ASCOQLTY26 @ascocancer.bsky.social